HIV

ViiV Healthcare announces US FDA approval of the first-ever dispersible tablet formulation of dolutegravir, Tivicay PD, a once-daily treatment for children living with HIV

By
1 Mins read
146
0
Share
Reading Time: < 1 minute

ViiV Healthcare, the global specialist HIV company majority-owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders Read More

146
0
Share
Related posts
HIV

Man cured of HIV through groundbreaking transplant from his brother in first-of-its-kind procedure

By
1 Mins read
Reading Time: < 1 minuteA man living with HIV has been cured of the devastating disease in a pioneering transplant, doctors have revealed. Read More
HIV

Nigeria to receive HIV prevention drug in March, says NACA

By
1 Mins read
Reading Time: < 1 minuteThe National Agency for the Control of AIDS has announced that Nigeria will take delivery of Lenacapavir, a groundbreaking HIV prevention drug…
HIV

African HIV services face double blow of cuts from both Trump and UK

By
1 Mins read
Reading Time: < 1 minuteGroups fighting to prevent HIV on the ground in Senegal face a double blow of aid cuts – with Britain announcing a £150m cut to their biggest donor,…
Subscribe to our Blog

Let's stay in touch. Subscribe to our blog and get our best content in your inbox. 

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.